Bedrocan grows standardised cannabis strains with a consistent composition of cannabinoids and terpenes. Our cannabis products are independently tested for desired properties by specialised laboratories. Because of its pharmaceutical quality, and the possibility to export these products, many scientists have chosen to work with Bedrocan to undertake long-term scientific studies and clinical research projects. Click here for a study overview of Bedrocan products used in humans.
Bedrocan accounts for a wide range of (potentially) active components in our plants. By visualising up to 30 different cannabinoids and terpenes, we aim to reduce the endless number of popular varieties (also named cultivars) to a manageable, chemically distinct set of varieties (or chemovars). The products currently available through Bedrocan are listed below.
Introduced in 2003, the Bedrocan product is the first variety developed and named after the company itself. It is a sativa strain (Cannabaceae Cannabis sativa L.) featuring 22% THC, with a CBD-level below 1%. It’s the most widely used medicinal cannabis offered by the Dutch Ministry, and has been used in more research than other products. Bedrocan is the brand name for this variety and is available in flos form.
Introduced in 2005, the Bedrobinol product is bred in-house by Bedrocan. Bedrobinol is the brand name for this sativa strain Cannabaceae Cannabis sativa L.. Its THC-level can be considered medium strength, standardised at 13,5%, with a CBD-level below 1 %.
Bedrobinol is available in flos form.
Introduced in 2007, Bediol is one of the first cannabis varieties developed specifically to have a higher CBD content. The effects of CBD are distinctly different from THC. Bediol is the brand name for this sativa variety (Cannabaceae Cannabis sativa L.).
Bediol has a balanced ratio of THC 6.3% and CBD 8%. Because it is easily tolerated, physicians often prescribe Bediol for patients who previously have not used cannabis as a medicine. This strain was bred in-house by Bedrocan, specifically to meet the needs of patients.
Bediol is available in granular form.
Introduced in 2011, Bedica was developed in response to mounting evidence of a real difference in the effects of sativa and indica varieties.
Characteristic differences between indica and sativa strains can be found in the presence of aromatic compounds (terpenes) in the plant. Bedica contains a high amount of the myrcene terpene, which is known to have a calming effect. Bedica is the brand name for this indica variety (Cannabaceae Cannabis sativa L.).
Bedica contains 14% THC with less than 1% CBD.
Bedica is also available in granular form.
Introduced in 2014, Bedrolite is a so-called CBD-only product, with less than 1% THC and 9% CBD. The virtual absence of THC means it does not have psychoactive properties. Bedrolite has become the preferred choice of a number of patients with severe, intractable (untreatable) forms of epilepsy. Bedrolite is the brand name for this sativa variety (Cannabaceae Cannabis sativa L.).
Bedrolite is available in granular form.